Involvement of trihydroxyconjugated bile salts in cholesterol assimilation by bifidobacteria
- PMID: 9003583
- DOI: 10.1007/s002849900148
Involvement of trihydroxyconjugated bile salts in cholesterol assimilation by bifidobacteria
Abstract
To determine the conditions of cholesterol assimilation,various strains of Bifidobacterium species were cultured in the presence of cholesterol and bile salts. During culturing, Bifidobacterium breve ATCC 15700 assimilates cholesterol in the presence of oxgall at pH values lower than 6. This strain was selected to study the influence of conjugated (taurocholic acid) and deconjugated (cholic acid) bile salts on cholesterol assimilation. B. breve ATCC 15700 assimilated cholesterol(up to 51%) when cultures were undertaken in the presence of taurocholic acid, whereas less than 13% of the initial amount ofcholesterol was measured in the cells in the presence of cholic acid. Cultured in the presence of six individual di- or trihydroxyconjugated bile salts, bifidobacteria strains assimilated cholesterol. This assimilation appeared to be more important in the presence of trihydroxyconjugated bile salts (tauro- and glycocholic acids). It is concluded thattrihydroxyconjugated bile salts are involved in the assimilation of cholesterol by bifidobacteria.
Similar articles
-
Bifidobacteria strain behavior toward cholesterol: coprecipitation with bile salts and assimilation.Curr Microbiol. 1996 Sep;33(3):187-93. doi: 10.1007/s002849900098. Curr Microbiol. 1996. PMID: 8672088
-
Bifidobacteria and probiotic effects: action of Bifidobacterium species on conjugated bile salts.Curr Microbiol. 1995 Jul;31(1):23-7. doi: 10.1007/BF00294629. Curr Microbiol. 1995. PMID: 7767225
-
Effects of Lactobacillus amylovorus and Bifidobacterium breve on cholesterol.Lett Appl Microbiol. 2000 Aug;31(2):154-6. doi: 10.1046/j.1365-2672.2000.00792.x. Lett Appl Microbiol. 2000. PMID: 10972719
-
Importance of microbial defence systems to bile salts and mechanisms of serum cholesterol reduction.Biotechnol Adv. 2018 May-Jun;36(3):682-690. doi: 10.1016/j.biotechadv.2017.12.005. Epub 2017 Dec 14. Biotechnol Adv. 2018. PMID: 29248683 Review.
-
[Choleresis, choleretics and motility of the bile ducts].Tijdschr Gastroenterol. 1975;18(1):35-48. Tijdschr Gastroenterol. 1975. PMID: 1099718 Review. German. No abstract available.
Cited by
-
Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.Exp Diabetes Res. 2012;2012:902917. doi: 10.1155/2012/902917. Epub 2012 May 3. Exp Diabetes Res. 2012. PMID: 22611376 Free PMC article. Review.
-
Administration of Metabiotics Extracted From Probiotic Lactobacillus rhamnosus MD 14 Inhibit Experimental Colorectal Carcinogenesis by Targeting Wnt/β-Catenin Pathway.Front Oncol. 2020 Jun 2;10:746. doi: 10.3389/fonc.2020.00746. eCollection 2020. Front Oncol. 2020. PMID: 32670864 Free PMC article.
-
The gut-heart axis: unveiling the roles of gut microbiota in cardiovascular diseases.Front Cardiovasc Med. 2025 May 26;12:1572948. doi: 10.3389/fcvm.2025.1572948. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40491716 Free PMC article. Review.
-
Gut microbiota and cardiovascular disease: opportunities and challenges.Microbiome. 2020 Mar 14;8(1):36. doi: 10.1186/s40168-020-00821-0. Microbiome. 2020. PMID: 32169105 Free PMC article. Review.
-
Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review).Exp Ther Med. 2024 Sep 11;28(5):427. doi: 10.3892/etm.2024.12716. eCollection 2024 Nov. Exp Ther Med. 2024. PMID: 39301250 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases